Recent Disclosures of Clinical Candidates and SMR Award Lecture

1 December 2016 09:00-17:00, London, United Kingdom

The Society for Medicines Research announce the 2016 SMR Award for Drug Discovery is awarded to the Bristol-Myers Squibb team responsible for OPDIVO® (nivolumab), a fully human anti-programmed death receptor-1 (PD-1) antibody approved to treat several cancers. The award will be received by Dr Francis Cuss, Executive Vice President & CSO R&D, Bristol-Myers Squibb, who will deliver the SMR Award Lecture entitled ‘The Discovery, Development and Delivery of Opdivo’.
The symposium will also feature an international line up of speakers from AstraZeneca, J&J Belgium, GSK, Pfizer and Merck KgGA presenting on the discovery and development of novel therapeutic agents which have recently progressed towards or into clinical trials. The programme includes a variety of mechanistic approaches for the novel therapeutics including small molecules, monoclonal antibodies and a drug re-purposing and will cover therapeutics areas including oncology, anti-infectives, inflammation and anaemia. ‚Äč
Sponsorship & supporting organisations
European Federation of Medicinal Chemistry
Liverpool Chirochem
National Heart and Lung Institute

National Heart and Lung Institute, Guy Scadding Building, Dovehouse St, London, SW3 6JZ, United Kingdom

Organised by
Society Of Medicines Research
Contact information
Showing all upcoming events
Start Date
End Date
Subject area
Event type


E-mail Enquiry